Sfoglia per Autore
Evaluation of software tools for Bayesian estimation on population models with count and continuous data
2015-01-01 Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Mezzalana, Enrica; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo
Methods and tools for multiscale modelling in Systems Pharmacology: a review
2016-01-01 Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Massaiu, Ilaria; Sauta, Elisabetta; Tosca, ELENA MARIA; Vitali, Francesca; Zucca, Susanna; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo
Current mathematical models for cancer drug discovery
2017-01-01 Carrara, Letizia; Lavezzi, SILVIA MARIA; Borella, Elisa; DE NICOLAO, Giuseppe; Magni, Paolo; Poggesi, Italo
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions
2018-01-01 Bartolucci, R.; Lavezzi, S. M.; Tosca, E. M.; Melillo, N.; Grandoni, S.; Borella, E.; Pasotti, L.; De Nicolao, G.; Magni, P.
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues
2018-01-01 Lavezzi, S. M.; Mezzalana, E.; Zamuner, S.; De Nicolao, G.; Ma, P.; Simeoni, M.
Mathematical modeling of efficacy and safety for anticancer drugs clinical development
2018-01-01 Lavezzi, S. M.; Borella, E.; Carrara, L.; De Nicolao, G.; Magni, P.; Poggesi, I.
Methodological and practical issues in TMDD modeling with application to oncology
2018-01-26 Lavezzi, SILVIA MARIA
Pharmacokinetic Models for Drug and Metabolites Including First Pass Effects: A Priori and A Posteriori Identifiability Analysis
2019-01-01 Lavezzi, S. M.; Zhang, J.; Magni, P.; De Nicolao, G.; Iavarone, L.
Assessing drug effect from distributional data: A population approach with application to Duchenne Muscular Dystrophy treatment
2019-01-01 Lavezzi, S. M.; Rocchetti, M.; Bettica, P.; Petrini, S.; De Nicolao, G.
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial
2019-01-01 Lavezzi, S. M.; de Jong, J.; Neyens, M.; Cramer, P.; Demirkan, F.; Fraser, G.; Bartlett, N.; Dilhuydy, M. -S.; Loscertales, J.; Avigdor, A.; Rule, S.; Samoilova, O.; Goy, A.; Ganguly, S.; Salman, M.; Howes, A.; Mahler, M.; De Nicolao, G.; Poggesi, I.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Evaluation of software tools for Bayesian estimation on population models with count and continuous data | 1-gen-2015 | Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Mezzalana, Enrica; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo | |
| Methods and tools for multiscale modelling in Systems Pharmacology: a review | 1-gen-2016 | Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Massaiu, Ilaria; Sauta, Elisabetta; Tosca, ELENA MARIA; Vitali, Francesca; Zucca, Susanna; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo | |
| Current mathematical models for cancer drug discovery | 1-gen-2017 | Carrara, Letizia; Lavezzi, SILVIA MARIA; Borella, Elisa; DE NICOLAO, Giuseppe; Magni, Paolo; Poggesi, Italo | |
| Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions | 1-gen-2018 | Bartolucci, R.; Lavezzi, S. M.; Tosca, E. M.; Melillo, N.; Grandoni, S.; Borella, E.; Pasotti, L.; De Nicolao, G.; Magni, P. | |
| MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues | 1-gen-2018 | Lavezzi, S. M.; Mezzalana, E.; Zamuner, S.; De Nicolao, G.; Ma, P.; Simeoni, M. | |
| Mathematical modeling of efficacy and safety for anticancer drugs clinical development | 1-gen-2018 | Lavezzi, S. M.; Borella, E.; Carrara, L.; De Nicolao, G.; Magni, P.; Poggesi, I. | |
| Methodological and practical issues in TMDD modeling with application to oncology | 26-gen-2018 | Lavezzi, SILVIA MARIA | |
| Pharmacokinetic Models for Drug and Metabolites Including First Pass Effects: A Priori and A Posteriori Identifiability Analysis | 1-gen-2019 | Lavezzi, S. M.; Zhang, J.; Magni, P.; De Nicolao, G.; Iavarone, L. | |
| Assessing drug effect from distributional data: A population approach with application to Duchenne Muscular Dystrophy treatment | 1-gen-2019 | Lavezzi, S. M.; Rocchetti, M.; Bettica, P.; Petrini, S.; De Nicolao, G. | |
| Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial | 1-gen-2019 | Lavezzi, S. M.; de Jong, J.; Neyens, M.; Cramer, P.; Demirkan, F.; Fraser, G.; Bartlett, N.; Dilhuydy, M. -S.; Loscertales, J.; Avigdor, A.; Rule, S.; Samoilova, O.; Goy, A.; Ganguly, S.; Salman, M.; Howes, A.; Mahler, M.; De Nicolao, G.; Poggesi, I. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile